Q3FY17 Result: Indoco Remedies Ltd
Bhagyashree Vivarekar / 27 Jan 2017
Indoco Remedies Ltd. reported its results for the quarter ended December 31, 2016 during market hours today. The total sales for Q3FY17 came in at Rs 278.19 crore, which represents a 1 per cent sequential decline and 6.82 per cent YoY increase.
Indoco Remedies Ltd. reported its results for the quarter ended December 31, 2016 during market hours today.
The total sales for Q3FY17 came in at Rs 278.19 crore, which represents a 1 per cent sequential decline and 6.82 per cent YoY increase.
The operating profit (EBIT) for the quarter amounted to Rs 25.15 crore and the EBIT margin stood at 9.04 per cent.
The company reported PAT of Rs 17.59 crore, which represents a sequential QoQ decline of 20.52 per cent and a YoY decline of 7.32 per cent.
Indoco Remedies Ltd is an Indian company engaged in the business of manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
The company's stock opened at Rs 271 on the BSE and rose 0.5 per cent over previous close of Rs 269.85. It touched day's high of Rs 274.8 in early trading.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.